SCHEMBL723574

SCHEMBL723574

COc1cc(C(=O)c2nc(-c3ccc(N(C)C)cc3)[nH]c2S(=O)(=O)c2ccccc2)cc(OC)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
MAPT P10636 3/20 0.42
KDM4E B2RXH2 3/20 0.42
TUBB4A P04350 9/20 0.42
TUBB P07437 9/20 0.42
TUBA3C P0DPH7 9/20 0.42
TUBA1B P68363 9/20 0.42
TUBA4A P68366 9/20 0.42
TUBB4B P68371 9/20 0.42
TUBB3 Q13509 9/20 0.42
TUBB2A Q13885 9/20 0.42
TUBB8 Q3ZCM7 9/20 0.42
TUBA3E Q6PEY2 9/20 0.42
TUBA1A Q71U36 9/20 0.42
TUBA1C Q9BQE3 9/20 0.42
TUBB6 Q9BUF5 9/20 0.42
TUBB2B Q9BVA1 9/20 0.42
TUBB1 Q9H4B7 9/20 0.42
ABCC1 P33527 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724184 0.89 TUBB4A (0.50) MAPTKDM4ETUBB4ATUBBTUBA3C
SCHEMBL2463917 0.80 TUBB4A (0.44) LMNAMAPTKDM4ETUBB4ATUBB
SCHEMBL2466370 0.77 AURKA (0.40) LMNAMAPTCYP1A2CYP3A4CYP2C19
SCHEMBL2465985 0.76 TUBB4A (0.47) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL724351 0.74 TUBB4A (0.51) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL725555 0.72 ALDH1A1 (0.49) LMNAMAPTTUBB4ATUBBTUBA3C
SCHEMBL2468921 0.70 CYP1A2 (0.56) LMNAMAPTKDM4EALDH1A1GAA
SCHEMBL2465972 0.70 TUBB1 (0.49) LMNAMAPTTUBB4ATUBBTUBA3C
SCHEMBL2464347 0.69 TUBB4A (0.49) LMNAMAPTTUBB4ATUBBTUBA3C
SCHEMBL15135682 0.68 ALDH1A1 (0.49) LMNAMAPTTUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4504183-A1 METHODS OF TREATING INFLUENZA AND POXVIRUS VIRAL INFECTIONS Veru Inc. (US) 2025-02-12 EP disclosed
EP-4320151-A1 METHODS OF TREATING INFLAMMATION Veru Inc. (US) 2024-02-14 EP disclosed
WO-2023196632-A1 METHODS OF TREATING INFLUENZA AND POXVIRUS VIRAL INFECTIONS VERU INC. (US) 2023-10-12 WO disclosed
WO-2021203100-A1 METHODS OF TREATING CORONAVIRUS VERU INC. (US) 2021-10-07 WO disclosed
WO-2012027481-A9 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2013-10-10 WO disclosed
EP-2608671-A1 COMPOUNDS FOR TREATMENT OF CANCER Gtx, Inc. (US) 2013-07-03 EP disclosed
WO-2012027481-A1 COMPOUNDS FOR TREATMENT OF CANCER GTX, INC. (US) 2012-03-01 WO disclosed